The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Boosting pazopanib exposure by splitting intake moments: A prospective pharmacokinetic study in cancer patients.
 
Stefanie L. Groenland
No Relationships to Disclose
 
Ruben A.G. van Eerden
No Relationships to Disclose
 
Remy B Verheijen
Employment - AstraZeneca
Stock and Other Ownership Interests - Aduro Biotech; AstraZeneca
 
Alwin Huitema
No Relationships to Disclose
 
Ron H.J. Mathijssen
Research Funding - Astellas Pharma (Inst); Bayer Holding (Inst); Boehringer Ingelheim (Inst); Roche (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Pfizer; Roche
 
Neeltje Steeghs
Research Funding - AB Science (Inst); Amgen (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); Blueprint Medicines (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Deciphera (Inst); Genentech (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst); Merus (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)